Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transcription and cohesin direct domain boundary spatial positioning and are linked to Friedreich's ataxia.

Molecular cell·2026

Same author

Polyphenol-Enriched Fraction from Chestnut Shells as a Source of Bioactive Compounds for Friedreich Ataxia.

Molecules (Basel, Switzerland)·2026

Same author

Stable Isotope Labeling in Bacteria Enables Characterization and Quantification of Frataxin Protein in a Friedreich's Ataxia Zebrafish Model.

Analytical chemistry·2025

Same author

Design and validation of cell-based potency assays for frataxin supplementation treatments.

Molecular therapy. Methods & clinical development·2025

Same author

Friedreich ataxia: what can we learn from non-GAA repeat mutations?

Neurodegenerative disease management·2025

Same author

A Multianalyte Machine Learning Model to Detect Wrong Blood in Complete Blood Count Tube Errors in a Pediatric Setting.

Clinical chemistry·2025

Search research articles

Related Experiment Video

Updated: Feb 17, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Therapeutic developments in Friedreich ataxia.

Robert B Wilson¹

¹Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA. WilsonR@mail.med.upenn.edu

Journal of Child Neurology

|July 14, 2012

Summary

Friedreich ataxia is a severe inherited neurodegenerative disorder with no current therapy. Research focuses on increasing frataxin protein to combat mitochondrial dysfunction and oxidative stress.

Area of Science:

Neurogenetics
Mitochondrial Biology
Cardiovascular Disease

Background:

Friedreich ataxia is an inherited neurodegenerative and cardiodegenerative disorder.
It stems from reduced expression or function of the mitochondrial protein frataxin.
This leads to impaired iron-sulfur cluster formation, mitochondrial iron overload, and oxidative stress.

Purpose of the Study:

To review current therapeutic strategies for Friedreich ataxia.
To highlight initiatives targeting frataxin levels and mitochondrial dysfunction.

Main Methods:

Review of preclinical and clinical research on Friedreich ataxia therapies.
Analysis of biochemical defects and their therapeutic implications.

Main Results:

More Related Videos

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Related Experiment Videos

Last Updated: Feb 17, 2026

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Multiple therapeutic approaches are under investigation.
These include strategies to boost frataxin expression, reduce mitochondrial iron, and mitigate oxidative stress.

Conclusions:

Understanding Friedreich ataxia's biochemical basis has spurred innovative therapeutic development.
Several promising initiatives are advancing through preclinical and clinical stages, offering hope for future treatments.